RopesTalk

Ropes & Gray LLP
undefined
Jun 14, 2023 • 42min

There Has to Be a Better Way?: Miracle on the Hill: How to Build Consensus and Achieve Results in Divided Organizations

During some of the most divisive times in U.S. history, a small group of Democrats and Republicans defied all odds and learned to work together to get things done. It’s an inspiring story of success that you almost never hear about in Congress. On this episode of There Has to Be a Better Way?, co-hosts Zach Coseglia and Hui Chen talk with Dr. Marian Currinder, a political scientist and former professional staffer to a bipartisan congressional committee during an extremely partisan time, to learn about how a committee that seemed set up to fail thwarted expectations to pass more than 200 recommendations in four years.
undefined
Jun 8, 2023 • 1h 4min

Treacherous Shoals—Navigating Growing Anti-ESG Sentiment: Recent Developments Impacting Asset Managers

Over the last year-plus, there has been a growing anti-ESG movement in the United States. Most of the focus has been on asset managers. As the leading asset management practice, Ropes & Gray has been in the trenches advising clients on these issues on a daily basis. On this podcast, Ropes & Gray thought leaders come together for a timely in-depth discussion of the most recent anti-ESG developments and the demands asset managers are navigating. During the podcast, they discuss fiduciary duties, antitrust, proxy advisors, state legislation, greenwashing and consumer protection claims and ERISA considerations. The participants provide concrete compliance tips. They also provide their predictions for the future.Ropes & Gray partners Josh Lichtenstein, Samer Musallam, Chong Park, Amy Roy and Rob Skinner share their thoughts. The discussion is moderated by Michael Littenberg, partner and global head of the firm’s ESG, CSR and business & human rights practice.
undefined
Jun 1, 2023 • 30min

Value-based Care Collides with Competition: Recent Developments on the East Coast

On this episode of Ropes & Gray’s Value-based Care Collides with Competition podcast series, health care attorneys Brett Friedman, Ben Wilson and Natalie LaRue discuss the recent developments and trends related to health care access, cost and quality on the East Coast. Efforts by these East Coast states mirror the efforts on the West Coast instates like Oregon, Washington, Nevada and California, and in some cases, pre-date them. They talk about the deal impacts of existing laws in Connecticut and Massachusetts, a newly passed law in New York that will take effect this summer, and proposed state laws in Maine and North Carolina, focusing on what these laws could mean for health care transactions in these states, especially those involving private equity and venture-capital-funded entities.
undefined
May 31, 2023 • 34min

There Has to Be a Better Way?: GE’s Global Investigations Chief Counsel Katy Choo Discusses the Art of Investigations

Co-hosts Zach Coseglia and Hui Chen speak with Katy Choo, VP and chief counsel of global investigations at General Electric. Katy is one of the most highly respected figures in corporate internal investigations, and has led a multitude of investigations both as a prosecutor and in-house at GE. On this episode of There Has to Be a Better Way?, Katy shares her “humanizing” approach to investigations and compliance, and the many questions she asks in her search for answers.
undefined
May 23, 2023 • 10min

Why Conduct a GP-Led Secondary?

On this Ropes & Gray podcast, asset management attorneys Amanda Persaud and Kevin White discuss reasons why a sponsor would consider conducting a GP-led secondary transaction. Ropes & Gray has recently been ranked as the #1 firm in the 2023 Secondaries Investor Annual Survey, and the market for these transactions has grown significantly over the last several years. Many sponsors who have not previously been involved in this market have entered this market and found the transactions to be highly appealing. Amanda and Kevin explore several of the rationales for why sponsors have found these transactions so appealing.
undefined
May 22, 2023 • 27min

The Applicability of the SEC’s Proposed Custody Rule to Real Estate

The SEC has proposed sweeping changes to its custody rule that would impose new obligations on registered investment advisers with respect to physical assets such as real estate. On this Ropes & Gray podcast, regulatory partner Nicole Krea discusses how these requirements would affect investment advisers in their management of real estate assets.
undefined
May 18, 2023 • 20min

R&G Tech Studio Presents: Strategic Transactions Co-Leader Marko Zatylny

On this episode of the R&G Tech Studio, strategic transactions co-lead Marko Zatylny sits down with technology, media & telecommunications co-lead Ed Black to discuss how the current regulatory and geopolitical environments are affecting how tech companies are evaluating future opportunities globally.
undefined
May 18, 2023 • 18min

Value-based Care Collides with Competition: Recent Developments on the West Coast

On this episode of Ropes & Gray’s Value-based Care Collides with Competition podcast series, health care attorneys Jenn Romig and Jaclyn Freshman discuss the deal impacts of new state laws in California, Oregon and Washington focused on regulating health care access, cost and quality. 
undefined
May 17, 2023 • 41min

There Has to Be a Better Way?: Compliance Leader and Ex-Marine Patrick McGowan Digs Into the Predictive Power of Data Analytics

On this episode of There Has to Be a Better Way?, co-hosts Zach Coseglia and Hui Chen talk to Patrick McGowan, senior director for global compliance auditing and monitoring at industrial tech innovator Fortive. With a JD, MBA and background in forensic accounting, Patrick discusses how using quantitative methods to analyze seemingly small compliance issues can lead to big human insights.
undefined
May 10, 2023 • 21min

Non-binding Guidance: Recent Developments in Oncology Drug Development

This installment of Ropes & Gray’s podcast series Non-binding Guidance explores recent regulatory developments related to the development and approval of oncology drugs in the U.S. and Europe. On this episode, hear from Ropes & Gray FDA regulatory partner Josh Oyster and head of the European life sciences practice Lincoln Tsang as they compare approaches from FDA and E.U. legislation, and discuss what that means for companies researching and developing new oncology products for a global market.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app